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ABSTRACT: It is becoming increasingly accepted that to
understand and model the bacterial colonization and infec-
tion of abiotic surfaces requires the use of a biofilm model.
There are many bacterial colonizations by at least two pri-
mary species, however this is difficult to model in vitro. This
study reports the development of a simple mixed-species
biofilm model using strains of two clinically significant bacte-
ria: Staphylococcus aureus and Pseudomonas aeruginosa
grown on nanoporous polycarbonate membranes on nutrient
agar support. Scanning electron microscopy revealed the
complex biofilm characteristics of two bacteria blending in
extensive extracellular matrices. Using a prototype wound
dressing which detects cytolytic virulence factors, the viru-
lence secretion of 30 single and 40 mixed-species biofilms
was tested. P. aeruginosa was seen to out-compete S.
aureus, resulting in a biofilm with P. aeruginosa dominating.
In situ growth of mixed-species biofilm under prototype
dressings showed a real-time correlation between the viable
biofilm population and their associated virulence factors, as
seen by dressing fluorescent assay. This paper aims to pro-
vide a protocol for scientists working in the field of device
related infection to create mixed-species biofilms and demon-
strate that such biofilms are persistently more virulent in real
infections. VC 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B:
Appl Biomater 00B: 000–000, 2018.
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INTRODUCTION
Modern society has beneﬁted from the application of inva-
sive medical devices in healthcare, treatment, and recovery
of patients, for example 30 million indwelling urinary cathe-
ters were used in United States alone annually.1 Likewise, a
global increase in the use of various invasive devices, such
as central venous catheters, mechanical heart valves, pace-
makers, prosthetic joints, dialysis catheters, dental implants,
and contact lens has been reported.2 The primary purpose
of these devices is to aid treatment and bring better health-
care outcomes to the patients, but infection associated with
them have become signiﬁcant.2 Wound dressings, for exam-
ple, are surface dwelling devices and have been used for the
protection/healing of wounds. They are polymeric materials
in contact with skin and tissue and whilst deigned to pre-
vent infection, can often facilitate surface bacterial growth.
Such microbial contamination, probably originated from
patient’s skin ﬂora, increases the risk of device-induced host
infection, negatively impact the quality of treatment, and
potentially affect the intended function of the device.
Bacterial contamination primarily exists in an extracellular
polymeric substance (EPS) network, adhered onto the
indwelling device surface as a bioﬁlm.
Bacteria, of single or multispecies bioﬁlms, recovered
from infected indwelling devices mostly include Staphylococ-
cus aureus, Pseudomonas aeruginosa, Enterococcus faecalis,
Escherichia coli, Proteus mirabilis, and Klebsiella pneumo-
niae.3 Many bacteria achieve the mutual beneﬁts in bioﬁlms,
from sharing of resources to avoidance of host immune
clearance and a better protection against the environmental
threats such as antibiotics/antimicrobials. As bacteria grow
into a bioﬁlm, the changes in gene expression and regula-
tion often results in increased pathogenicity and overall
virulence activity of bioﬁlm, and increased antimicrobial
resistance compared with free ﬂoating planktonic cells.4,5
Device related infections involving multi-species bioﬁlm are
more persistent: it becomes critical to understand and iden-
tify the factors associated with the formation of mixed-
species bioﬁlms and their enhanced pathogenicity over the
infected hosts.6
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Infection due to an invasive device depends on three
main in situ factors: bacteria, device, and host, but among
them the bacteria factor is of primary importance. As such,
the role of bacteria in bioﬁlm formation on a device surface,
from initial surface contamination to irreversible establish-
ment of polymeric network, is the subject of research inter-
est. Understanding device related infections requires the
development of in vitro/ex vivo bioﬁlm models that mimic
the mixed-species nature and their growth on surfaces.
Many modern wound dressings claim to control local bacte-
rial population, for example by elution of silver ions. How-
ever, the clinical evidence for the efﬁcacy of such dressings
is often mixed, with single trial studies frequently reporting
success, but systematic reviews such as those by the
Cochrane Library being more cautious in their conclusions.7
It is notable that most in vitro evaluations of wound dress-
ings still use very simple test methods to evaluate efﬁcacy,
such as a reduction in viable colony forming units (CFU)
after immersing swatches of dressing in planktonic culture
of a single species/strain of bacteria and visualization of
zones of inhibition around dressings on culture plates.8
There are more systematic tests that have been developed
to quantify the general efﬁcacy of antimicrobial fabrics, such
as the Japanese Industrial Standard,9 but these still have
methodological ﬂaws if being used to quantify the likely
behaviour of a wound dressing on a patient.
The occurrence of bacteria in the bioﬁlm state in
wounds has only gained clinical acceptance fairly
recently,10,11 although the formation of bioﬁlms on abiotic
surfaces such as ventilator tubing has long been observed.12
In particular, S. aureus and P. aeruginosa are the two bacte-
rial pathogens most commonly isolated in many microbial
studies of acute wounds, and it is generally accepted that S.
aureus is an early stage colonizer, where P. aeruginosa is fre-
quently isolated later, especially in burns.13 Studies of
chronic co-infected S. aureus and P. aeruginosa wound sug-
gest that such coinfections are more virulent than mono-
species infections, suggesting a synergistic relationship
between the two organisms.6 Gabrilska and Rumbaugh14
review various in vivo and in vitro bioﬁlm models of mixed-
species infection ranging from very simple static models
such as microtitre plate assays to the Calgary peg model,
which utilizes the Robbins device for controlled nutrient
feeding, to more complex models such as the Lubbock
chronic wound model.15 A burn speciﬁc bioﬁlm model on
gauze, which was designed to be transferred to a lab animal,
has been developed to try and create the common microbi-
ology of burns, the Zurich burn bioﬁlm model.16
A prototype diagnostic dressing (PDD) targeting the bac-
terial virulence factors has been developed that has been
used to test the bioﬁlm virulence.17 It consists of phospho-
lipid vesicles containing self-quenched carboxyﬂuorescein,
dispersed in a hydrogel matrix.18 Bioﬁlm virulence factors,
such as delta toxin, phenol soluble modulin, and rhamnoli-
pid lyse the lipid vesicle membrane thus releasing carboxy-
ﬂuorescein which is diluted within the hydrogel matrix,
giving a clear visual indication of the presence of
critical colonization: bacterial density dependent molecular
mechanisms switch on virulence factor secretion at high
bacterial density.12 The mixed-species bioﬁlm model devel-
oped in this study was a colony bioﬁlm model19 and
intended to test and validate the PDD, but has potential uti-
lization for alternative wound dressings or other medical
devices with antibacterial or bacterial sensing capabilities.
This article presents the methodology for preparing
mixed-species model bioﬁlms. We discuss the test results of
virulence from such bioﬁlms comprised of two strains of S.
aureus and P. aeruginosa randomly chosen from a library of
20 S. aureus and 10 P. aeruginosa strains and inoculated
onto a nanoporous polycarbonate (PC) membrane placed on
nutrient agar. The pores allow diffusion of small nutrient
molecules to the growing bioﬁlm but impede cells spreading
into the underlying agar. The PDD were placed on the 44-
to 48-h aged bioﬁlms and used to quantify the relative viru-
lence factor production of single and mixed-species bioﬁlms.
Viable cells were also recovered from the bioﬁlms and used
to quantify the number of CFU of each species of bacteria in
the bioﬁlm of different start inocula.
MATERIALS AND METHODS
Materials
Phospholipid 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC) was purchased from Avanti Polar Lipids. Cholesterol,
5,6-carboxyﬂuorescein, fetal calf serum (HyClone), 4–(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), hex-
amethyldisilazane (HMDS), paraformaldehyde, glutaralde-
hyde, and agarose were purchased from Sigma Aldrich, U.K.
10,12-Tricosadiyonic acid (TCDA) was acquired from Alfa
Aesar, U.K. Two types of modiﬁed HEPES buffers, containing
NaCl and NaOH, with or without 50 mmol dm23 5,6-carbox-
yﬂuorescein were prepared in deionized water (18.2 MX
cm, Millipore) and sterilized. Luria broth (LB), tryptic soy
broth (TSB), brain heart infusion (BHI), Baird Parker (BP),
and cetrimide culture agars were purchased from Fluka and
Fisher Scientiﬁc, U.K. Broths were prepared in deionized
water, sterilized, and used in liquid culture of bacteria. Like-
wise sterile BHI agar plates were prepared in petridishes
and used as a nutrient substrate for the growth of bioﬁlm.
The dressing mold was made of a square plastic plate with
an array of short cylindrical studs to create an embossed
hydrogel dressing. Bioﬁlms were formed on 19 mm diame-
ter nanoporous PC membranes with the average pore diam-
eter of 200 nm (Whatman). Artiﬁcial wound ﬂuid (AWF)
was aseptically prepared using fetal calf serum mixed in
equal volume with a sterilized mixture of 0.85% NaCl (w/v)
and 0.1% peptone (w/v), and prepared in aliquots of 500
mL small tubes followed by storage at 2208C until further
use.
Preparation of vesicles
Aseptic preparation of vesicles was previously reported.20
In summary, 100 mmol dm23 of lipids, cholesterol, and
TCDA in chloroform were mixed in the ratio of 55:20:25
(%vol) respectively. One milliliter of lipid mixture was dried
in a vacuum desiccator before thoroughly rehydrated in
5 mL of sterile HEPES buffer containing 50 mmol dm23 5,6-
2 THET ET AL. MIXED-SPECIES BIOFILM INFECTION MODEL AND THEIR VIRULENCE
carboxyﬂuorescein. Following heating in hot water bath and
three freeze-thaw cycles, the solution was then extruded
three times at 558C through a nanoporous polycarbonate
membrane (200 nm pore) using an extruder (LF-50, Aves-
tin). The nonencapsulated dyes were removed using gel ﬁl-
tration columns (DNA grade, NAP-25, GE Healthcare, U.K.)
and the vesicles were stored at 48C for 6 days before cross-
linking under UV light (254 nm, Hamamatsu, Japan). Cross-
linked vesicles were stored at 48C until further use.
Prototype diagnostic dressing production
Agarose gel (2%) was used as a dressing material to
hydrate the vesicles. The production of prototype diagnostic
dressing (PDD) was previously described and the PDD, in
activated and nonactivated forms was shown in Figure 1.18
In short, sterilized molten agarose in HEPES buffer was
aseptically molded to result a 2 mm thick square gel slab
carrying an array of cylindrical wells in it. These wells were
individually ﬁlled with a mixture of agarose (0.7%) and
vesicles (35 mL/well).
Bacterial culture
Twenty S. aureus and ten P. aeruginosa clinical strains were
used to produce the bioﬁlm model with the two additional
strains—E. coli (DH5a) and S. aureus (Agr-) for the negative
controls. DH5a was a nonpathogenic bacterium used for
laboratory cloning, and Agr- was a mutant strain in which
pathogenic Agr activity was eliminated. S. aureus (MRSA
252) was also used for the initial assessment of mixed-
species bioﬁlm models. All clinical strains used in this study
are listed in Table I.4,5,21 Bacteria were individually cultured
from a single colony in 10 mL of broth in a shaker incuba-
tor for 18 h at 378C, resulting in 109 CFU mL21 in a ﬁnal
culture. Then 18-h cultures of S. aureus and P. aeruginosa
were diluted to 103 and 105 folds in HEPES respectively
and used as initial inocula for bioﬁlm growth.
In vitro single and mixed-species bioﬁlm models
Thirty-two single-species bioﬁlms (Table I) and forty mixed-
species bioﬁlms (Table II) were prepared in triplicate for
this study. The protocol for making bioﬁlms was described
in our previous study.18 Nanoporous PC membranes were
disinfected in 70% ethanol for 15 min, allowed to dry and
positioned on BHI agar with the smooth side facing up. Pre-
treatment on each membrane was 30 mL of AWF spread and
dried. For single-species bioﬁlm, diluted bacteria were pre-
mixed with sterile HEPES in equal volume and 50 mL of the
mixture was used on each membrane. For mixed-species
bioﬁlms, diluted bacteria of each pair of selected strains
was pre-mixed in equal volume before pipetting 50 mL of
the mixture onto each PC membrane. The agar plates were
then incubated at healthy skin temperature (338C) for 44–
48 h.22
Bioﬁlm characterization
All bioﬁlms were characterized by scanning electron micros-
copy (SEM) and plating and colony counting. For SEM study,
bioﬁlms were ﬁxed in a mixture of 1.5% glutaraldehyde and
3% paraformaldehyde in water for an hour. They were then
sequentially dehydrated in 50, 70, 80, 90 and 100% ethanol
for 10 min each before drying in HMDS for 30 s. Then the
bioﬁlms were mounted on an aluminum stud and dried in a
vacuum desiccator for 18 h. Following the sputtered coating
with gold, they were imaged by SEM (JEOL SEM6480LV).
For quantitative analysis, each bioﬁlm was placed in a tube
with 5 mL of sterile HEPES and vortexed for 1 min before
further stripping in a sonicating water bath for 2 3 15 min.
After an additional 1 min vortex, the bioﬁlm extract was seri-
ally diluted in HEPES and plated on LB and TS agars for P.
aeruginosa and S. aureus single-specie bioﬁlms respectively.
FIGURE 1. Prototype diagnostic dressing (PDD) as seen under a (254 nm) UV light showing (a) no fluorescent activation for noninfected and (b)
fluorescent activation for infected conditions.
TABLE I. List of Bacterial Strains Used in Development of
Single and Mixed-Species In Vitro Biofilms (*MRSA strain)
S. aureus P. aeruginosa Controls
2 25 67 112 45124 45468 E. coli DH5a
3 38 69 114 45291 45498 S. aureus Agr-
10 49 71 126 45311 45506 MRSA 252
16 52 82* 160 45400 45666
21 56 101 233 45445 45701
ORIGINAL RESEARCH REPORT
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH B: APPLIED BIOMATERIALS | MONTH 2018 VOL 00B, ISSUE 00 3
For mixed-species bioﬁlms, the extract was plated on selec-
tive BP and cetrimide agars for S. aureus and P. aeruginosa,
respectively. All experiments were tested in triplicate with
ﬂuorescent, and CFU data were presented in average
value with standard deviation statistically analyzed by
student’s t test.
In situ dressing response to growing bioﬁlm study
S. aureus (MSSA 16) and P. aeruginosa (45311) were grown
in a mixed-species bioﬁlm at the interface between the PDD
and the nanoporous PC membrane on BHI agars in a NUNC-
6 well plate. A single ply sterile cotton gauze was used
between the membrane and the PDD to provide a space for
the bioﬁlm to grow. While incubating at 338C, the PDD ﬂuo-
rescence in triplicate was measured 4 hourly up to 36 h
using a FluoStar Omega microplate reader (BMG Labtech,
U.K.), with excitation and emission wavelengths of 485 nm
and 520 nm, respectively. For in situ quantitative analysis,
bioﬁlms were grown in parallel, and each bioﬁlm removed
every 4 h for stripping, plating, and colony counting to
determine the viable bioﬁlm cells. The populations of S.
aureus and P. aeruginosa in each stage of mixed-species bio-
ﬁlm growth was then correlated to the PDD ﬂuorescence.
Bioﬁlm cells reduction assay
For a therapeutic efﬁcacy testing, the bioﬁlm cell reduction
by the hydrogel dressing containing octenidine hydrochlo-
ride was studied using two single-species bioﬁlms of
selected strains of S. aureus (MSSA 2) and P. aeruginosa
(45124). Octenidine has been used as an effective antiseptic
agent/coating against S. aureus and P. aeruginosa bio-
ﬁlms.23,24 Two types of hydrogel, with and without 2% octe-
nidine hydrochloride were provided from Scapa Healthcare
(First Water) U.K. Aquacel AgTM (1.2% ionic Ag from Conva-
Tec) in hydrated form was used as a positive control. Each
hydrogel, cut into 3 3 3 cm2 was rehydrated in 1.5 mL ster-
ile HEPES for 30 min. Rehydration aids hydrogels better
release of octenidine. Likewise, each Aquacel AgTM dressing,
cut into the same size was rehydrated in 1 mL of sterile
HEPES. Then 24-hold 12 single-species bioﬁlms in triplicate
were transferred onto hydrated hydrogels, Aquacel AgTM
(positive control) and agarose gel (negative control) before
incubation for 24 h at 378C. Hydrogels were removed in the
end and bioﬁlms were stripped for plating and colony
counting.
RESULTS
Evaluation of mixed-species bioﬁlm
Despite using the equal initial inocula, P. aeruginosa had
reached a bioﬁlm population 5 to 6 orders of magnitude
greater than S. aureus. Figure 2(a–c) shows 48-h old, mixed-
species bioﬁlms grown from a ﬁxed initial inoculum of S.
aureus (105 CFU) with the varying inocula (105, 103, and 1
CFU) of P. aeruginosa. A relatively higher inoculation
ensured S. aureus to be able to compete with P. aeruginosa
in bioﬁlm. It appeared that S. aureus colonized the surface
ﬁrst, followed by a late growth of P. aeruginosa as seen in
Figure 2. Equal initial inocula produced the bioﬁlm with
excess P. aeruginosa, but two orders of magnitude higher
initial inocula of S. aureus over P. aeruginosa provided the
bioﬁlms with a balanced population. Hence the initial inoc-
ula of S. aureus (105) and P. aeruginosa (103) CFU per mem-
brane were used in this study.
Characterization of single and mixed-species bioﬁlms
SEM revealed the bioﬁlm of cocci (S. aureus) and rod (P.
aeruginosa) bacteria in Figure 2(d,e). It shows a mixed-
species bioﬁlm with an abundant EPS network. S. aureus
appeared in small clusters as well as within the larger
agglomerates of P. aeruginosa. The reason for scattered bio-
ﬁlm appearance of S. aureus was not well understood but
the motility might be the reason for a broader coverage of
P. aeruginosa, compared with the nonmotile S. aureus.
Single-species bioﬁlms and their virulence activity
Figure 3(a) shows the viable cell count recovered from eight
selected single-species bioﬁlms (the remaining results can
be found in Supporting Information Figure S1). It was
noticed that a matured bioﬁlm always reached an average
cell density of 1010 CFU which was one order of magnitude
higher than the same species cultured in planktonic mode
(planktonic data not shown). The lipolytic activity of these
bioﬁlms, quantiﬁed by ﬂuorescent activation of PDD, was
shown in Figure 4(b). The virulence effect of the identical
strains cultured in both planktonic and bioﬁlm modes was
also measured. About the half of S. aureus strains in
TABLE II. List of S. aureus and P. aeruginosa Strains for Mixed-Species Biofilms
No Strains No Strains No Strains No Strains
1 21 45498 11 821 45124 21 211 45400 31 381 45191
2 233145666 12 161 45311 22 101 45124 32 561 45498
3 821 45291 13 101 45311 23 491 45666 33 101145468
4 671 45445 14 160145445 24 126145701 34 381 45468
5 21 45400 15 31 45124 25 112145445 35 211 45291
6 491 45311 16 711 45468 26 821 45506 36 233145701
7 251 45666 17 491 45701 27 160145506 37 561 45400
8 691 45400 18 161 45124 28 521 45506 38 521 45498
9 711 45311 19 251 45701 29 126145666 39 112145666
10 160145124 20 114145445 30 821 45311 40 112145498
Strains were randomly selected and paired and refer to Table I for strain number and bacteria species.
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planktonic growth showed virulence, but the same strains
when grown into single-species bioﬁlms elicited a weaker
virulence response (Figure 4). In contrary P. aeruginosa
strains, regardless of the growth mode, showed a high viru-
lence, as measured by the PDD.
Mixed-species bioﬁlms and their virulence activity
Forty mixed-species bioﬁlms were grown (Supporting Infor-
mation Figure S2) and most of them displayed an inner
circular zone where S. aureus grew before being outgrown
by P. aeruginosa. The viable cell counts recovered from
ﬁve selected mixed-species bioﬁlms were presented in
Figure 3(b) (the remaining data in Supporting Information
Figure S3). Most of them triggered the ﬂuorescent response,
above 40% threshold, in 24 h [Figure 5(a) and the remain-
ing data in Supporting Information Figure S4]. PDD ﬂuores-
cence, as seen under a UV lamp, in response to the controls
and the selected mixed-species bioﬁlms were also shown in
Figure 5(b,c). It was also noticed that S. aureus strains
which previously were not much lytic against PDD in single-
species bioﬁlms were found to be associated with virulence
in mixed-species bioﬁlms. The increase in virulence activity
of mixed-species bioﬁlm was seen in P. aeruginosa (45291)
with S. aureus strain of MSSA 82 (Figure 5). These S. aureus
FIGURE 2. Effect of equal and unequal initial inocula of S. aureus (MRSA 252) and P. aeruginosa (45445) in 48 h mixed-species biofilms: (a)
Equal initial inocula of S. aureus and P. aeruginosa (105 CFU each), (b) Unequal inocula of S. aureus (105 CFU) and P. aeruginosa (103 CFU), and
(c) Unequal inocula of S. aureus (105 CFU) and P. aeruginosa (1 CFU). Note an inner circle of uneven biofilm surface in (b) belongs to S. aureus
colonies (white) which was later outgrown by P. aeruginosa colonies (yellow) to the edge of membrane. SEM images of (d) single-species bio-
film of P. aeruginosa (45311) and (e) mixed-species biofilm following an initial inoculation of 105 CFU of S. aureus (MSSA 16) and 103 CFU of P.
aeruginosa (45311). All biofilms were grown on nanoporous PC membrane on BHI agar surface at 378C for 48 h (Scale bar: 5 mm).
FIGURE 3. (a) Total number of viable cells (in CFU/biofilm) recovered from eight selected single-species biofilms and (b) five mixed-species bio-
films. Despite using higher the initial inocula of S. aureus, CFU of S. aureus in mixed-species biofilms vary, in comparison to CFU of P. aerugi-
nosa. The remaining CFU data of all single and mixed-species biofilms were presented in Supporting Information Figure S1 and S3 respectively.
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and P. aeruginosa strains in their single-species bioﬁlm were
relatively less virulence and only activated the PDD ﬂuores-
cence less than the threshold ﬂuorescent response [Figure
4(b)], but their resultant response was >40% when they
were grown in mixed-species bioﬁlms. Similar increase in the
PDD ﬂuorescent was also observed in S. aureus 49 and 69
strains when they were grown into mixed-species bioﬁlms. It
was hypothesized that the virulence secretion is closely
related to the population density of bacteria.25 Employing
quorum sensing (QS) mechanism, a bioﬁlm cells awaits to
reach a threshold population which then infects and causes
an irreversible damage to the host if the infection is left
untreated.26,27
Real-time PDD response to bioﬁlm cells (in situ analysis)
As most of P. aeruginosa strains out-competed S. aureus in
mixed-species bioﬁlms, a time-dependent study of in situ
PDD response to bioﬁlm growth was carried out using
(161 45311) as a mixed-species model. S. aureus (MSSA
16) was selected as it displayed relatively high response
(Figure 4). Figure 6(a) shows the in situ bioﬁlm cell counts
and the respective ﬂuorescent response in every 4 h. Both
bacteria showed a growth retardation between 4 and 8 h
before exponential growth. S. aureus (MSSA 16) growth
reached to a turning point after 16 h, reaching a peak CFU
of 109 before a declining down to 106 in the end. Interest-
ingly, at the 16 h time point, P. aeruginosa (45311), with
only a population of 107 CFU outnumbered and started its
elimination against a relatively larger population of S.
aureus. P. aeruginosa however reached and maintained
above 1010 CFU after 20 h of incubation. Figure 6(a) also
depicted the kinetic response to growing bioﬁlms in situ.
The ﬂuorescence response was observed when CFU of both
species reached 109 after 16 h of incubation.
FIGURE 4. Effect of bacterial growth mode on fluorescent response of lipid vesicles. (a) Fluorescent response of lipid vesicles after incubation
with planktonic culture of 20 S. aureus in TSB and 10 P. aeruginosa strains in LB (18 h culture) for 24 h, and (b) fluorescent response of PDD to
single-species biofilms after incubation at 338C for 24 h. Biofilms were formed at 338C for 44 h before putting them on PDD. Fluorescent
response was calculated with respect to the reference dressings containing 250 mM 5,6-carboxyfluorescein. Fluorescence above the dotted line
exhibits visible switch on from PDD (*p< 0.05). Numbers on top of each column represent the respective strain number of the bacteria tested.
FIGURE 5. Fluorescent response of PDD after incubation with mixed-species biofilms at 338C for 24 h. (a) Fluorescent response of PDD in tripli-
cate to each mixed-species biofilm is calculated based on positive control dressing with 250 mM 5,6-carboxyfluorescein. Dotted line indicates the
notable dressing switch on (*p<0.005). (b) Control plate with no biofilm, E. coli (DH5a) biofilm, S. aureus (Agr-) biofilm and positive control Tri-
ton (first to fourth columns, from left to right) and (c) PDD fluorescent response to selected mixed-species biofilms (right).
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Bioﬁlm cells reduction assay
It is accepted that the bioﬁlm cells are much more resistant
to antibiotics/antiseptics than free-ﬂoating planktonic cells
of same species.28 To realize the concept of therapeutic
dressing, an attempt was made to see the effect of octeni-
dine hydrochloride treatment in two single-species bioﬁlms
and the results are shown in Figure 6(b). It was observed
that 2% octenidine containing hydrogels reduced viable
cells count of both bioﬁlms by approximately two orders of
magnitude compared with control hydrogels without octeni-
dine. Octenidine also showed more effectiveness against P.
aeruginosa than S. aureus. The efﬁcacy of octenidine against
bioﬁlms was similar to the positive control Aquacel AgTM
dressings.
DISCUSSION
This study pointed out the growth-mode-dependent viru-
lence activity of bacteria. In single-species bioﬁlms, most of
S. aureus appeared to be relatively less virulent than the
bioﬁlms of P. aeruginosa despite bioﬁlm population reached
above 1010 CFU (Figure 3). Such a growth-mode-dependent
virulence could be explained by a genetic regulation fol-
lowed by QS. In S. aureus, accessory gene regulator (agr)
system controls the downregulation of virulence genes as
bacteria cells grow into bioﬁlm, resulting in the reduced vir-
ulence activity.12,29
The ﬂuorescent activation of each PDD in Figure 5(a)
was directly related to the virulence factors associated with
bioﬁlms.18 Previous P. aeruginosa studies suggested that
rhamnolipid was identiﬁed as the primary virulence factor
which were highly cytolytic against lipid bilayer mem-
branes.18 P. aeruginosa deploys rhamnolipid as the bio-
surfactants to internalize the host cell membrane30 and for
the uptake of hydrophobic molecules for the bioﬁlm
growth.31 It was also reported that P. aeruginosa used two
QS systems, namely las and rhl to control the expression of
coding Type 4 pilus-dependent twitching motility which
played a vital role in facilitating host infection.32 Despite las
activity of P. aeruginosa bioﬁlms decreased with time, the
rhl system responsible for the expression of rhamnolipid,
remained active for more than a week.33 This might explain
the active virulence activities of P. aeruginosa in all growth
conditions as observed in Figure 4.
In mixed-species bioﬁlms, P. aeruginosa clearly out-
competed S. aureus regardless of the unequal initial inocula,
resulting in the imbalance bioﬁlm cell population, and it
was the direct outcome of the competition between S.
aureus and P. aeruginosa [Figure 3(b)]. The multifactorial
mechanism of P. aeruginosa-mediated elimination of S.
aureus in cystic ﬁbrosis infection was proposed34 and P. aer-
uginosa secreted a whole range of molecules to overcome S.
aureus, including anti-staphylococcal inhibitor mole-
cules,35,36 proteases,37 and extracellular virulence factors.38
Such enhanced bioﬁlm virulence was attributed by the co-
growth and competition between two species of bacte-
ria.39,40 P. aeruginosa-mediated elimination of S. aureus was
population dependent, as it occurred when both bioﬁlm
cells reached 108 CFU in in situ growth.
CONCLUSION
A method development of a simple and portable mixed-
species bioﬁlm has been reported. The primary limitation of
growing an in vitro mixed-species bioﬁlm with a balanced
population of both S. aureus and P. aeruginosa was over-
come by a method of unequal initial inocula. Mixed-species
bioﬁlms comprising 10 P. aeruginosa and 20 S. aureus clini-
cal strains were grown on nanoporous PC membranes and
tested. Bioﬁlms grown for 48 h evidenced the cohabitation
of both resident species growing together within the EPS
network, with the population of P. aeruginosa higher than S.
aureus in most bioﬁlms. Using 30 single and 40 mixed-
species bioﬁlms, the effects of bioﬁlm growth modes in their
bioﬁlm virulence activities were tested using an assay of
colorimetric PDD containing lipid vesicles.
FIGURE 6. (a) Time dependent variation of biofilm cells (CFU) and in situ fluorescent response of PDD throughout the biofilm formation of S.
aureus (MSSA 16) and P. aeruginosa (45311) in mixed-species biofilms and (b) Reduction of viable biofilm cells (CFU) in single-species biofilms
of S. aureus (MSSA 2) and P. aeruginosa (45124) using 2% octenidine hydrochloride containing hydrogel. Negative controls are biofilms only
and biofilms on neutral hydrogel. Positive control is biofilms on silver containing fabric (Aquacel AgTM). All tests are in triplicate. 2% Octenidine
containing hydrogel reduced the viable biofilm cells (CFU) to two orders of magnitude lower than controls, showing slightly more effectiveness
against P. aeruginosa single-species biofilm of P. aeruginosa. (*p<0.005)
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It was observed that the P. aeruginosa was the key path-
ogen, dominating the overall virulence of mixed-species bio-
ﬁlms. Such a virulence attenuation was strain-dependent
and related to the strains of species and the viable bacteria
population. In situ growth of a selected mixed-species bio-
ﬁlm correlated between the viable bioﬁlm population and
their time-dependent activation against the lipid vesicles in
PDD. A hydrogel containing 2% octenidine was found to be
able to reduce bioﬁlm cells in single-species bioﬁlms of
both bacteria within 24 h interface. Such an in vitro mixed-
species bioﬁlm model could be the choice for researchers in
their bioﬁlm related clinical studies for the device related
infections.
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